While PPSV23 is recommended for senior adults, researchers say there is "uncertainty" about its effectiveness in infection-prone senior adults with rheumatoid arthritis.
Prompting Medical Students to Choose Rheumatology
Facing a growing shortage, rheumatology is looking to attract the next generation of providers.
International Medical School Students Filling the Rheumatologist Shortage
Retaining international medical students, addressing student loan debt, mentoring and case-based teaching could possibly reverse the rheumatologist shortage, analysis says.
Baricitinib vs. Placebo or Adalimumab for Rheumatoid Arthritis
Compared to placebo and adalimumab, the addition of once-daily oral baricitinib produced significant clinical improvements in RA patients, research shows.
Incorporating the Bone Health Life Chart into your Practice
In this article, Dr. Ralph Bovard explores osteopenia and osteoporosis. He also presents a case for creating a BMD Life Chart to track bone mineral density over a patient's lifetime.
Biologics for Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis
In this slideshow, we review the biologics currently approved to treat adults with moderate-to-severe plaque psoriasis and psoriatic arthritis.
Brodalumab Approved for Psoriasis
The U.S. Food and Drug Administration has approved brodalumab (Siliq) for the treatment of adults and moderate-to-severe plaque psoriasis.
A Clinical Update on Baricitinib for Rheumatoid Arthritis
Patient-reported outcomes are in line with clinical trial results for baricitinib, an international research team reports.
Greater Risk of Stroke after Herpes Zoster Infection
Is this on your radar? A herpes zoster infection can lead to stroke in some RA patients. Learn more in this interview with Dr. Jeffrey Curtis.
Obesity's Role in the Treatment and Development of Disease
Obesity was a common theme at RNS16 this year in which speakers touched on obesity as a cause of disease onset and even as one that can prevent therapeutic treatments from working.
Healthcare Reform for Rheumatologists, Take-a-Way Lessons
In this interview, Herbert S. B. Baraf, MD, FACP, MACR, provides his take-a-ways from ACR/ARHP 2015 about new reimbursement policies affecting private practice rheumatologists.
Sounding Out Arthritis #7: Ultrasound-Guided Knee Injection
This two-part video demonstrates how to use ultrasound to guide viscosupplementation or steroid injection of the arthritic knee, interspersed with the corresponding ultrasound images.
The Puzzling Parts of Lyme Arthritis
In this slideshow, we highlight excerpts from a study that assesses treatment options after a Lyme disease infection. The authors question the value of delaying DMARD treatment after an autoimmune disease diagnosis.
Methotrexate for RA: Oral or Subcutaneous?
In this slideshow, we feature a review by Italian rheumatologists who compare subcutaneous and oral methotrexate outcomes in rheumatoid arthritis patients.
Myocardial Inflammation in Rheumatoid Arthritis
Heart disease in rheumatoid arthritis is well known, but whether it's present in RA patients with no known heart disease or risk factors is not as well known.
By clicking Accept, you agree to become a member of the UBM Medica Community.